(Q36916152)

17 August 2017

Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics (English)

1 reference

estrogen-receptor positive breast cancer

17 August 2017

0 references

1 reference

11

Wolfgang Eiermann

0 references

Mitch Dowsett

12

object named as

Mitch Dowsett

1 reference

17 August 2017

Matthew J Ellis

1

1 reference

17 August 2017

Yu Tao

2

1 reference

17 August 2017

Jingqin Luo

3

1 reference

17 August 2017

Roger A'Hern

4

1 reference

17 August 2017

Dean B Evans

5

1 reference

17 August 2017

Ajay S Bhatnagar

6

1 reference

17 August 2017

Hilary A Chaudri Ross

7

1 reference

17 August 2017

Alexander von Kameke

8

1 reference

17 August 2017

William R Miller

9

1 reference

17 August 2017

Ian Smith

10

1 reference

17 August 2017

language of work or name

English

0 references

publication date

23 September 2008

1 reference

Journal of the National Cancer Institute

17 August 2017

1 reference

17 August 2017

100

1 reference

17 August 2017

19

1 reference

17 August 2017

1380-1388

1 reference

Neoadjuvant endocrine therapy for locally advanced breast cancer

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556704

The molecular portraits of breast tumors are conserved across microarray platforms

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556704

Proliferation marker Ki-67 in early breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556704

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556704

TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation : An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556704

Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556704

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556704

Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556704

Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer--a study from the IMPACT trialists

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556704

Individualized care for patients with cancer - a work in progress

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556704

Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556704

Neoadjuvant endocrine therapy as a drug development strategy

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556704

Letrozole inhibits tumor proliferation more effectively than tamoxifen independent of HER1/2 expression status

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556704

Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556704

Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556704

Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer

4 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18812550

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18812550

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparison of immunocytochemical and biochemical assays for estrogen receptor in fine needle aspirates and histologic sections from breast carcinomas

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18812550

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/JNCI/DJN309

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

18812550

1 reference